scPharmaceuticals Announces Furoscix NDA Resubmission

4 years ago

by David Miller

949 Views

Written by David Miller

BURLINGTON, Mass.–(BUSINESS WIRE)–Jul. 1, 2020– scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance…Original Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

View all posts

[mwai_chat window="true" fullscreen="true"]

You may also like

About the author

David Miller

Don`t Leave Yet!